Agitation Clinical Trial
Official title:
A Prospective Survey of Emergent Agitation Following Craniotomy: Incidence, Risk Factors and Outcomes
Agitation is a significant clinical issue in anesthesiology and critical care medicine. Several studies have carried out to survey the epidemics of agitation in post-anesthesia care unit and intensive care unit, and results revealed that agitation had an adverse impact on outcomes. To our clinical experience, agitation can occur in postoperative neurosurgical patients, and is often difficult to manage. However, agitation in this subset of patients is poorly evaluated. In present study, adult patients following craniotomy will be enrolled consecutively, and incidence, risk factor and outcome of emergent agitation will be investigated. The results of the study will provide basic data for prevention and treatment of agitation in postoperative neurosurgical patients.
The study will enroll 120 consecutive adult patients admitted to Neuro-ICU for post-operative care following craniotomy. Sedation-Agitation Scale (SAS) will be evaluated and documented every hour or as needed during stay in ICU by nurse on duty. Emergent agitation is defined as SAS of 5 to 7 at anytime during the first 24 hr of ICU stay.Patients are divided into 2 groups: non-agitation group (SAS 1-4) and agitation group (SAS 5-7).Data collection includes pre-operative records, events during anesthesia and operation, events during ICU stay, and outcomes. The primary outcome is complications such as self-removal of endotracheal tube, central venous or bladder catheters. The secondary and third outcomes are ICU stay and Glasgow Outcome Scale at hospital discharge, respectively. Incidence of agitation will be calculated to present an epidemiological knowledge. Univariate analyses between the two groups will be used for preliminary selection of model variables. Then stepwise block logistic regression will be applied to model the risk of agitation using significant univariate predictors. ;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02525991 -
Phase IV to Evaluate the Safety of Self-administered ADASUVE® in Agitated Patients Outside the Hospital Setting
|
Phase 4 | |
Recruiting |
NCT05557409 -
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation
|
Phase 3 | |
Completed |
NCT01976754 -
Safety Study of Dexmedetomidine in Septic Patients
|
N/A | |
Completed |
NCT01217541 -
Collaboration Between Department of Old Age Psychiatry and Nursing Homes
|
N/A | |
Withdrawn |
NCT00786318 -
Ziprasidone vs Standard Therapy for Agitated Patients in the ED
|
Phase 4 | |
Not yet recruiting |
NCT05974527 -
Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency Department
|
Phase 4 | |
Not yet recruiting |
NCT05522647 -
Detection of Risk Behaviors: Pilot Observational Study With Bedridden and Agitated Patients.
|
||
Recruiting |
NCT02590744 -
Effects of Preoperative Using of Eye Patches on Prevention of Emergence Agitation After Cataract Surgery
|
N/A | |
Recruiting |
NCT02164773 -
Addition of Magnesium Sulfate to Caudal to Prevent Postoperative Emergence Agitation.
|
Phase 4 | |
Completed |
NCT01524367 -
Effect of Single-dose Dexmedetomidine on Emergence Excitement in Adults With Nasotracheal Intubation After Orthognathic Surgery
|
Phase 4 | |
Completed |
NCT01501123 -
Pre-hospital Agitation and Sedation Trial: A Randomized Controlled Trial of Haloperidol Versus Midazolam for the Sedation of the Agitated Patient
|
N/A | |
Completed |
NCT01021696 -
Pain in Patients With Dementia and Behavioural Disturbances
|
Phase 2/Phase 3 | |
Recruiting |
NCT05397639 -
Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type
|
Phase 3 | |
Terminated |
NCT03044249 -
A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression
|
Phase 2 | |
Completed |
NCT05165914 -
Midazolam Effect on Agitation Postnasal Surgery
|
N/A | |
Completed |
NCT04010305 -
Sub-Lingual Dexmedetomidine in Agitation Associated With Schizophrenia
|
Phase 1 | |
Completed |
NCT02720705 -
Transbucal Dexmedetomidine for Prevention of Sevoflurane Emergence Agitation in Pre-school Children
|
Phase 2/Phase 3 | |
Completed |
NCT02428283 -
Scalp Nerve Block on Emergence Agitation
|
Phase 4 | |
Completed |
NCT00457366 -
A Comparison Study of the Efficacy of Quetiapine and Haloperidol in Agitated Adults in Emergency Room
|
Phase 4 | |
Terminated |
NCT00315900 -
Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursing Home Care Unit Patients With Dementia
|
Phase 3 |